Dianthus Therapeutics DNTH
NASDAQ DNTH
$88.05 +0.89 (+1.02%)
At close: Sep 30, 2026 · 4:00 PM EDT

Dianthus Therapeutics (DNTH) Liabilities and Shareholders Equity (2017 - 2025)

Updated

Dianthus Therapeutics (DNTH) reported Liabilities and Shareholders Equity of $530.92 million for Q4 2025, up 42.0% from $374.01 million a year earlier but down 8.1% from the prior quarter.

Analysis

Dianthus Therapeutics (DNTH) Liabilities and Shareholders Equity (2017 - 2025) Analysis & Trends

Dating back to Q4 2017, Dianthus Therapeutics' Liabilities and Shareholders Equity record includes 32 quarters.

  • Liabilities and Shareholders Equity has increased for three consecutive years, with a five-year compound annual growth rate of 26.9% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $374.01 million in FY2024 (+108.5%), $179.41 million in FY2023 (+115.9%), $83.11 million in FY2022 (-56.2%) and $189.93 million in FY2021 (+17.5%).
  • Five-year quarterly Liabilities and Shareholders Equity spans a low of $78.64 million in Q2 2023 and a high of $577.45 million in Q3 2025.
  • Year over year, Liabilities and Shareholders Equity gained in six of the last eight quarters, with growth averaging 125.6%.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q2 2024 (growth of 369.2%); the low point was Q1 2023 (a decline of 57.1%).
  • Per Business Quant data, the three quarters before Q4 2025 came in at $577.45 million (Q3 2025), $326.08 million (Q2 2025) and $348.58 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Dianthus Therapeutics 3.77 Bn 3.72 Bn - 530.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 530.92 Mn
Sep 30, 2025 577.45 Mn
Jun 30, 2025 326.08 Mn
Mar 31, 2025 348.58 Mn
Dec 31, 2024 374.01 Mn
Sep 30, 2024 354.25 Mn
Jun 30, 2024 368.96 Mn
Mar 31, 2024 382.46 Mn
Dec 31, 2023 179.41 Mn
Sep 30, 2023 192.46 Mn
Jun 30, 2023 78.64 Mn
Mar 31, 2023 83.44 Mn
Dec 31, 2022 83.11 Mn
Sep 30, 2022 164.12 Mn
Jun 30, 2022 175.12 Mn
Mar 31, 2022 194.39 Mn
Dec 31, 2021 189.93 Mn
Sep 30, 2021 206.24 Mn
Jun 30, 2021 220.38 Mn
Mar 31, 2021 144.62 Mn
API Access

Dianthus Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=DNTH&period=max&api_key=YOUR_API_KEY